Cannabix Technologies Inc (USOTC:BLOZF) has announced the commercial launch of its long-anticipated Marijuana Breath Test (MBT) system, marking a major milestone in the evolution of cannabis detection technology. The Vancouver-based company revealed that it has begun a phased commercial rollout of the system, delivering initial units to select commercial customers across multiple industries while preparing to scale up production in the coming months.
The launch comes at a time when cannabis legalization continues to expand across North America and internationally, creating a growing demand for reliable tools capable of determining recent cannabis use rather than historical consumption.
Addressing a Critical Gap in Cannabis Testing
Traditional drug testing methods—such as urine, saliva, and hair analysis—have long been used to detect cannabis. However, these methods typically identify past cannabis exposure, which may have occurred hours, days, or even weeks earlier. This limitation has posed challenges for employers, law enforcement, and safety-sensitive industries that require testing methods capable of identifying recent use that may affect performance or safety.
The new MBT system from Cannabix is designed to fill that gap.
The technology detects delta-9 tetrahydrocannabinol (THC)—the primary psychoactive compound in cannabis—in human breath, enabling identification of cannabis consumption within roughly two to four hours after use. The system can detect THC at concentrations above 5 picograms per liter (pg/L), providing a targeted method for identifying recent consumption during the window most closely associated with potential impairment.
According to Cannabix, breath testing provides the most scientifically relevant approach for determining recent cannabis exposure because THC remains detectable in breath for only a short period after use, unlike other biological matrices that retain evidence long after intoxication has subsided.
How the MBT System Works
The MBT platform consists of three main components:
- Breath Collection Unit (BCU) – a handheld device used to collect breath samples.
- Disposable Breath Cartridges – single-use cartridges that capture aerosol particles in exhaled breath.
- Laboratory analysis performed by Omega Laboratories Inc. using a laboratory-developed testing method.
During testing, individuals breathe into the BCU, which collects aerosolized breath particles inside the cartridge. The cartridge is then sent for laboratory analysis, where specialized testing identifies the presence of THC and related cannabinoids.
Cannabix has designed the system to operate under a recurring revenue model. Organizations purchase the handheld BCU hardware, while ongoing revenue is generated through the continuous use of disposable cartridges required for each test.
Scientific Validation and Independent Research
Supporting the technology’s credibility, an independent peer-reviewed study confirming the system’s ability to detect THC in breath was recently published in the Journal of Analytical Toxicology.
The study, titled “Simultaneous Analysis of Δ9-THC, Δ8-THC, CBD, and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit,” demonstrated the system’s capacity to capture and analyze cannabinoids present in breath aerosols.
Peer-reviewed validation is an important milestone for emerging drug-testing technologies, particularly as regulators, employers, and courts increasingly scrutinize scientific evidence behind testing methods.
Preparing for Commercial Deployment
In preparation for the launch, Cannabix has completed several operational and technological milestones. These include:
- Enhancements to both the Breath Collection Unit and Breath Cartridge technology
- Initial validation work conducted by Omega Laboratories
- Integration of breath cartridges into Omega’s chain-of-custody and Laboratory Information Management System (LIMS)
- Establishment of manufacturing partnerships and quality assurance processes
- Successful FCC electronic emissions certification for the BCU hardware
- Development of end-user training materials, logistics systems, and customer support infrastructure
The company has also carried out early marketing initiatives alongside Omega Laboratories and AlcoPro Inc., a U.S. distributor specializing in alcohol and drug testing technologies.
Potential Applications Across Multiple Industries
The MBT system could have significant implications across sectors where workplace safety and regulatory compliance are critical.
Potential users include:
- Transportation and logistics companies
- Construction and heavy industry employers
- Energy and manufacturing sectors
- Law enforcement and roadside testing programs
- Workplace safety programs
As cannabis legalization expands, many organizations have struggled to balance employee rights with safety obligations. Tools that measure recent use rather than past consumption may help employers implement more precise and equitable policies.
A Growing Market for Cannabis Detection Technology
The commercial rollout of the MBT system highlights the broader shift toward next-generation impairment detection technologies. While alcohol breathalyzers have been widely used for decades, an equivalent tool for cannabis has proven far more difficult to develop due to the complex pharmacology of THC.
By focusing on breath aerosol analysis, Cannabix aims to create a practical solution that aligns more closely with the time frame of potential impairment.
As the company expands its rollout and production capabilities, the MBT system may represent a significant step forward in the development of real-time cannabis detection tools for workplaces, law enforcement, and public safety environments.